Canon Denshi Kabushiki Kaisha

Other

Meiji Seika Kaisha, Ltd.

Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai

Keio University

Nof Corporation

Yoshiyuki Koyama

Satoru Yajima

Yasutaka Morikoshi

Tomoko Ito

Tomio Takeuchi

Shinichi Kondo

Takahito Yoshizawa

Yusuke Inui

Shinya Nakawaki

Takashi Yoshida

Takaaki Aoyagi

Seiji Shibahara

Yasushi Murai

Daishiro Ikeda

Mitsugu Hachisu

Shigeharu Inoue

Kazuo Umezawa

Masahiro Onodera

Osamu Makabe

Toshinori Sato

Tuneo Okonogi

Keiichi Ajito

Sonoko Hirose

Tetsuji Yamaoka

Interchangeable lens for camera

A soft film, a sponge, or a sheet in the dried state is provided, which is capable of forming a hydrogel absorbing water or blood. The film is obtainable by preparing a film-state material in the dried state from either a solution of poly(acrylic acid) or a solution of polyvinylpyrrolidone, and bringing the film-state material into contact with the other remaining solution, and then drying or freeze-drying it.

Material to form a hydrogel

A blade driving device includes an opening forming member forming an opening portion, a pivotal member pivoting about the opening portion, blades configured to enter or exit from the opening portion upon receiving power transmitted from the pivotal member, a cover member arranged so that the pivotal member and the plurality of blades are located between the cover and the opening forming member, and engaging portions engaging the of blades with the opening forming member. The pivotal member comes into slidable contact with the engaging portions in a process of pivoting. A pivotal position of the pivotal member with respect to the opening forming member is defined by the engaging portions.

Blade driving device and image capturing device

A freeze-dried product of a complex containing (i) a nucleic acid, an oligonucleic acid or a derivative thereof, (ii) polyethyleneimine and (iii) hyaluronic acid or chondroitin sulfate. The freeze-dried product can be used to introduce a nucleic acid or an oligonucleotide into a cell.

Freeze-dried product for introducing nucleic acid, oligonucleic acid or derivative thereof

The present invention provides a polyethylene glycol derivative having sugar residue-containing side chains and carboxyl group-containing side chains, and a method of preparing the same. The present invention also provides a carrier for drug delivery systems and a carrier for gene transfer, both comprising the polyethylene glycol derivative.

Medical polymers and uses thereof

A novel actinonin derivative and a salt thereof are provided, which are useful as enzyme inhibitors and particularly have strong inhibitory activities against enkephalinase and angiotensin-converting enzymes. This actinonin derivative is represented by general formula (I): ##STR1## wherein R.sup.1 is sulfoxymethyl or carboxyl or a substituted carboxyl group selected from carboxamide, hydroxyaminocarbonyl and alkoxycarbonyl groups; and R.sup.2 is hydroxyl, alkoxy, hydroxyamino or sulfoxyamino group.

Actinonin derivatives and pharmaceutically acceptable salts thereof

As new compounds are now provided 14-O-(3,4-disubstituted benzoyl)adriamycins which are of low cytotoxicity and exhibit a high activity inhibitory to the reverse transcriptase of human immunodeficiency virus (HIV) and which can inhibit propagation of HIV.

Anthracycline derivatives having inhibitory activity against reverse

Cephalosporin compounds, intermediate compounds therefor, and processes for preparation thereof are described; the compounds have the formula (I) ##STR1## wherein R.sub.1 and R.sub.2 can each represent hydrogen, a hydroxyl group, a lower alkoxy group, or a substituted or unsubstituted phenylalkoxy group; R.sub.3 represents hydrogen or a lower alkyl group; R.sub.4 represents hydrogen or a hydroxyl group; and R.sub.5 represents ##STR2## wherein R.sub.6 is hydrogen, a lower alkyl group, an aminoalkyl group, an aminoaralkyl group, a --(CH.sub.2).sub.n --SO.sub.3 Na group, or a --(CH.sub.2).sub.n --COR.sub.9 group [wherein R.sub.9 is a hydroxyl group, an OM group (wherein M is an alkali metal), an alkoxy group, or an ##STR3## group, (wherein R.sub.10 and R.sub.11, which may be the same or different, can represent hydrogen or an alkyl group), and n is 0 or an integer of from 1 to 4]; R.sub.7 is hydrogen, a lower alkyl group, an amino group, or a substituted or unsubstituted aryl group; and R.sub.8 represents hydrogen or a lower alkyl group; or, a pharmaceutically acceptable salt thereof.

Cephalosporin compounds

Growing community of inventors

Tokyo, Japan

Yoshiyuki Koyama